Altavo is a medical device startup based in Dresden, Germany, focused on developing non-invasive silent speech technology to help individuals who have lost their voice, particularly those who have undergone laryngectomy due to tumor surgery. By leveraging machine learning and advanced sensor technology, Altavo aims to enhance speech rehabilitation and explore various applications beyond the medical field, ultimately improving the quality of life for its users.
PharmAI specializes in drug discovery through advanced chemoinformatics and structure analysis. Their offerings include focused library screening, scaffold diversification, and off-target identification, utilizing a knowledge-based approach and AI-driven technology to optimize compound libraries and enhance the precision of drug candidate identification. Their goal is to accelerate the drug discovery process while reducing costs and improving accuracy.
SEMRON is a technology startup focused on transforming artificial intelligence (AI) with innovative hardware. Their advanced CapRAM™ technology offers unmatched compute-in-memory power, significantly enhancing performance for AI-driven devices. SEMRON's 3D CapRAM™ architecture enables AI to run directly on smartphones, wearables, and headsets without relying on the cloud, aiming to create a future with faster, more efficient AI at the edge.
SpiNNcloud Systems focuses on developing a next-generation hybrid high-performance computing platform inspired by the human brain, known as SpiNNaker2. This platform enables seamless integration of deep learning, symbolic reasoning, and neuromorphic processing, allowing developers to create intelligent and efficient AI models with real-time capabilities and energy efficiency. By bridging the gap between biological models and AI, SpiNNcloud aims to empower the evolution of AI technologies for commercial applications.
Wandelbots is focused on redefining robotics automation through innovative software solutions that encompass planning, building, and operating robotic systems. They aim to foster a community for developers and engineers in the automation and robotics field, offering opportunities for collaboration and beta testing of their products.
A significant leap for Dresden, the establishment of the Biomedical Artificial Intelligence (BioAI) program marks an ambitious step in integrating artificial intelligence with biomedicine. This initiative promises transformative impacts on diagnostic and therapeutic procedures, effectively positioning Dresden at the forefront of biomedical research.
Dresden, a city known for its historical and cultural significance, is now poised to become a major player in the tech world. ParTec AG and Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have announced a groundbreaking initiative to build a 500-petaflop AI supercomputer, named 'ELBJUWEL'. This development marks a significant step for Germany in advancing artificial intelligence (AI) and quantum computing capabilities locally [source].
Dresden is at the forefront of integrating artificial intelligence into medical diagnostics. Researchers at University Hospital Dresden have been awarded the Digital Laboratory Funding Prize for their innovative work using AI to detect leukemia.